OBJECTIVE: Leptin is a hormone regulating weight in the mouse. Leptin regulates food intake and appetite. Leptin concentrations are increased in obese individuals suggesting resistance to its effect. However, there is considerable variability in leptin levels at each level of adiposity suggesting that environmental and genetic factors may regulate leptin concentrations. We examined whether subjects with decreased insulin sensitivity have increased leptin levels. METHODS: We used a radioimmunoassay to measure serum leptin levels and the hyperinsulinemic euglycemic clamp (with indirect calorimetry) to measure insulin sensitivity in 87 normoglycemic relatively lean men. RESULTS: Leptin levels were signi®cantly correlated with fasting insulin (r 0.58), insulin area (r 0.45), overall (r 70.57), non-oxidative (r 70.51) and oxidative (r 70.51) whole body glucose disposal (all P-values`0.001). After adjustment for body mass index, leptin levels remained signi®cantly correlated with fasting insulin (r 0.44), insulin area (r 0.40), overall (r 70.40), non-oxidative (r 70.28) and oxidative (r 70.33) whole body glucose disposal although the magnitude of the associations was considerably decreased. Leptin levels were signi®cantly related to insulin sensitivity in both less obese and more obese subjects. CONCLUSIONS: We conclude that leptin concentrations are related to insulin resistance and insulin concentrations in relatively lean normoglycemic men and these associations are to some extent independent of body mass index. Thus, subjects with insulin resistance may be relatively resistant to the effects of leptin.
Introduction
Obesity is strongly associated with the development of non-insulin dependent diabetes mellitus (NIDDM). 1, 2 The ob/ob mouse has been often used to study obesity. 3, 4 Recently, the gene responsible for obesity in the ob/ob mouse was cloned, along with its human analogue. 5 The OB gene is expressed in human tissues, especially adipose tissue. 6±8 The gene product, leptin is thought to regulate appetite and food intake. Since obese individuals overexpress the gene product (`leptin') it has been suggested that such subjects may be resistant to the effects of this hormone. 7±9 Administration of leptin to ob/ob mice reduces their body weight. 10 Assays for detection of leptin in human plasma have been developed and it has been shown that obese humans have increased levels of this hormone. 11, 12 Furthermore leptin levels decline in subjects who lose weight. 11, 12 Since there is residual variability in leptin levels at a given level of body mass index (BMI), 11, 12 environmental and genetic factors other than obesity may regulate leptin concentrations.
One possible regulator of leptin concentrations may be insulin levels or insulin resistance. Insulin has effects on the brain and has an important effect on the determination of food intake. 13 The administration of insulin and sulfonylurea increases weight in some subjects.
14 These agents are also associated with higher insulin concentrations. In contrast, in nondiabetic subjects insulin concentrations and insulin resistance are associated with weight loss. 15, 16 Serum leptin levels were signi®cantly correlated with insulin levels in one report using univariate analyses, but there was no signi®cant association after adjustment for percent body fat. 12 However, in a preliminary report, adjustment for body mass index attenuated the relation between serum leptin and insulin but it remained statistically signi®cant. 17 Leptin levels are increased during the night and lower around noon to mid-afternoon while the opposite is observed for insulin levels. 18 During the hyperinsulinemic euglycemic clamp 19, 20 insulin infusion did not increase leptin concentrations. However, during a 72 h insulin infusion leptin levels rose during the last 24 h. 20 These observations suggest a lack of acute effect of insulin in leptin concentrations but hyperinsulinemia and/or insulin resistance could have a long term effect on leptin concentrations. However, few data are available on the association of leptin levels and insulin sensitivity in humans which are somewhat contradictory.
Leptin levels were correlated with insulin sensitivity in obese but not in lean subjects. 19 However, in another report, leptin concentrations were signi®-cantly related to insulin resistance independently of obesity. 21 In this report we examine the association of serum leptin levels with insulin sensitivity (determined with the hyperinsulinemic euglycemic clamp with indirect calorimetry) and insulin concentrations in 87 normoglycemic men. We have previously reported the association between insulin sensitivity and obesity and body fat distribution in these subjects. 22 
Research design and methods
The subjects for this study were randomly selected from a population-based study aiming to associate insulin resistance with asymptomatic atherosclerosis in middle-aged, healthy men. 23 None of the 87 subjects had any chronic disease. Subjects did not take any drug treatment that could in¯uence carbohydrate metabolism. All subjects had normal glucose tolerance according to World Health Organization criteria. Furthermore, liver, kidney, and thyroid function tests were normal in every subject. Informed consent was obtained from all subjects. The protocol was approved by the University of Kuopio Ethics Committee.
Weight and height were measured in light clothing without shoes. Body mass index (BMI) (calculated as weight divided by height squared, kg/m 2 ) was used as an index of overall adiposity. Waist circumference was measured at the level of the umbilicus with the subjects standing and breathing normally. Hip circumference was measured at the level of greatest hip girth. Waist-to-hip ratio (WHR) was used as a measure of body fat distribution.
Study protocol
The subjects selected for the study were admitted to the metabolic ward for 2 d. On day 1, an OGTT (75 g glucose) was performed, and samples for plasma glucose and insulin were obtained at 0, 1 and 2 h. On day 2, the euglycemic clamp was performed.
Euglycemic hyperinsulinemic clamp
The degree of insulin sensitivity after a 12 h fast was evaluated by the euglycemic clamp technique as previously described in detail. 24 After baseline blood collection and measurement of gas exchange (see Indirect calorimetry), a priming dose of insulin (Velosulin Human, Novo Nordisk, Gentofte, Denmark) was administered during the initial 10 min in a logarithmically decreased manner to acutely raise serum insulin to the desired level, at which it was maintained by a continuous insulin infusion at a rate of 480 pmol/ m 2 /min 1 . Mean insulin during the last hour of the clamp study was 1080 pmol/l. Blood glucose was clamped at 5 mM for the 180 min by infusing 20% glucose at varying rates according to blood glucose measurements performed at 5 min intervals. Data were calculated for each 20 min interval during the third hour of the euglycemic clamp.
Indirect calorimetry
Indirect calorimetry was performed with a computerized¯ow-through canopy gas analyzer system (DELTATRAC, TM Datex, Helsinki, Finland) 25 as described previously. 26 On the day of the experiment, gas exchange (O 2 consumption and CO 2 production) was measured for the last 20 min of the euglycemic clamp. Protein, glucose, and lipid oxidation were calculated according to Ferrannini. 27 The fraction of carbohydrate nonoxidation during glucose clamp studies was estimated by subtracting the carbohydrate oxidation rate (determined by indirect calorimetry) from the glucose infusion rate (determined by the euglycemic clamp).
Analytical methods
Plasma glucose in the fasting state and during an oral glucose tolerance test and blood glucose during glucose clamp studies were measured by the glucose oxidase method (Glucose auto and Stat HGA-1120 analyzer, Daiichi, Kyoto, Japan). After centrifugation, plasma for insulin measurements was stored at 770 C until the analysis. Plasma insulin was determined by radioimmunoassay (Phadeseph Insulin RIA, Pharmacia, Uppsala, Sweden). Nonprotein urinary nitrogen excretion was measured by an automated Kjeldahl method. 28 Aliquots of fasting serum specimens were saved as contingency samples and were frozen at 770 C for an average of 6 y. Leptin concentrations were measured by a commercial radioimmunoassay (Linco Research, Inc., St. Louis, MO). 29 The intra-assay coef®cient of variation was 3.4±8.3% and inter-assay coef®cient of variation was 3.6±6.2%.
Data analysis in this report included t-tests (Table  1 ). Spearman correlations (Table 2) , non-parametric partial correlation analyses (Table 2) , multiple linear regression (Table 3 ) and analyses of variance ( Figures  2 and 3 ). Subjects were categorized as obese ( ! 27.3 kg/m 2 ) or non-obese (`27.3 kg/m 2 ) according to recommendations of the National Institute of Health Consensus Development Panel. 30 Glucose and insulin areas were calculated as the area under the glucose and insulin curves, respectively (0, 1 and 2 h). Adjustment for the effects of obesity on the relationship between insulin sensitivity and leptin concentrations was performed by partial correlational analyses, multiple linear regression and analyses of variance. All statistical analyses were done on the SAS software. Table 1 shows the clinical and metabolic characteristics of more obese vs less obese subjects (BMI below or above 27.3 kg/m 2 ). Obesity was associated with increased levels of leptin, fasting insulin, insulin area, fasting glucose and glucose area and decreased whole body glucose disposal.
Results
Figures 1a±1c show the association of leptin concentrations with fasting glucose (r 0.51), fasting insulin concentrations (r 0.58) and whole-body glucose disposal (r 70.57). All of these correlations were highly statistically signi®cant (P`0.001). Table 2 shows the Spearman correlations of leptin concentrations and body mass index with clinical and metabolic characteristics. Leptin concentration was signi®cantly positively correlated with body mass index, fasting insulin, insulin area, fasting glucose and glucose area while being negatively correlated with overall, oxidative and non-oxidative glucose disposal. Body mass index was signi®cantly inversely correlated with overall, oxidative and non-oxidative glucose disposal, and positively correlated with fasting insulin and glucose as well as their areas. After adjustment for body mass index, serum leptin levels remained signi®cantly related to overall, oxidative and non-oxidative whole body glucose disposal, fasting insulin, fasting glucose, glucose area and insulin area. After adjustment for both body mass index and WHR, serum leptin levels remained signi®cantly correlated with overall whole body glucose disposal (r 70.37) and fasting insulin (r 0.38) (both P`0.001). Alternatively, after adjustment for waist circumference, serum leptin levels also remained signi®cantly correlated with whole body glucose disposal (r 70.39) and fasting insulin (r 0.43) (P`0.001).
(We did not adjust for body mass index and waist circumference in the same model since body mass index and waist circumference were very highly correlated (r 0.82).
We next performed multiple linear regression with serum leptin levels as a dependent variable and age, body mass index, waist-to-hip ratio (WHR), fasting glucose and overall glucose disposal as independent variables (Table 3) . Overall glucose disposal remained signi®cantly related to leptin levels (P`0.001) ( Table  3) . We repeated these data analyses with waist circumference instead of body mass index and WHR as independent variables. In this model, overall glucose disposal was again related to leptin concentrations (P`0.001). We also set-up multiple regression analyses in which the dependent variable was leptin levels and glucose area and BMI were the independent variables. Both BMI (P`0.001) and glucose area (P 0.005) were signi®cant predictors of leptin concentrations. However, after also adding overall glucose disposal rate, glucose area continued to be a signi®cant predictor of leptin but the effect was considerably attenuated suggesting that the associa- P-values: * P`0.05; ** P`0.01; *** P`0.001. All variables are shown in the order of entry. The following variables were permitted to enter the regression model: age, fasting glucose, overall glucose disposal (GDR), waist-to-hip ratio (WHR) and body mass index.
tion of glucose with leptin could be due in part to the increased insulin resistance in these subjects. Figures 2 and 3 show leptin concentrations in relation to body mass index and overall glucose disposal or body mass index and fasting insulin. Leptin levels were related to overall glucose disposal (P 0.001) (Figure 2 ) and fasting insulin (P 0.002) (Figure 3 ) independently of obesity.
We also considered whether leptin might be more strongly related to overall glucose disposal only in more obese subjects (BMI ! 27.3 kg/m 2 ). However, leptin was correlated signi®cantly with overall glucose disposal both in more obese subjects (r 70.49, P 0.004) and in less obese subjects (r 70.53, P`0.001). In multiple linear regression analyses, the interaction of BMI 6 leptin was not statistically signi®cant (P 0.94).
Discussion
We found a signi®cant association between leptin and overall whole body glucose disposal. Interestingly, the association of leptin with overall whole-body glucose disposal was similar to that observed with oxidative or non-oxidative glucose disposal. Leptin concentrations were similarly correlated with overall glucose disposal in both more obese ( ! 27.3 kg/m 2 ) and less obese subjects. The association between leptin concentrations and insulin resistance remained statistically signi®cant after adjustment for overall adiposity (although the association was attenuated considerably) by a variety of multivariate techniques including partial correlation analyses, multiple linear regression and analysis of variance. Similarly, we found signi®-cant relations between insulin resistance and leptin after adjustment for body fat distribution assessed by either WHR or waist circumference. The lack of association between insulin sensitivity and leptin levels in non-obese subjects in a prior report 19 may have been due to the small number of non-obese subjects (n 14) and the inclusion of both men and women. The authors also did not adjust for obesity in evaluating the relationship between insulin sensitivity and leptin concentrations. One report using insulin sensitivity (as assessed by the frequently sampled intravenous glucose tolerance test) found leptin to be associated with insulin sensitivity in lean men. 21 We also found a signi®cant relation between serum leptin and insulin concentrations. These associations were signi®cant even though the population was relatively non-obese and male and thus the concentrations of leptin were low. We also con®rmed earlier reports in which leptin was correlated with the degree of obesity. 11, 12, 31 We have further shown that leptin remains signi®cantly correlated with fasting insulin after adjustment for BMI (Table 2 and Figure 3 ). Previous studies have yielded inconsistent results on this issue; in one study, leptin and insulin were signi®cantly correlated after adjustment for obesity 17 while in another study they were not. 12 The effect of insulin on leptin levels may not be due to an acute action since leptin concentrations are highest at night and lowest from noon to mid-afternoon while the opposite is observed for insulin levels. 18 Additionally, leptin levels did not change after short term insulin infusion in the hyperinsulinemic euglycemic clamp. 19, 20 Leptin concentrations did not increase after tolbutamide administration as part of the FSIGT. 21 One potential limitation of the present report is the use of an insulin assay which shows considerable cross-reactivity with proinsulin. However, since we have included only normoglycemic subjects, the proportion of proinsulin to insulin is likely to be low. 32 Moreover, we have previously shown that leptin levels are related to both`speci®c' insulin (which does not recognize proinsulin) and proinsulin levels. 17 Moreover, the use of immunoreactive insulin assay will not affect the measurement of insulin resistance by the hyperinsulinemic euglycemic clamp since exogenous insulin is used with the latter technique.
One weakness of the present report is that we use BMI as a measure of adiposity rather than having a gold standard measure of adiposity such as underwater weighing. We have previously shown in data from the San Antonio Heart Study that body mass index (separately in each sex) is as highly correlated with leptin concentrations 31 as is the association between leptin and body fat (assessed by bioimpedance). 12 We have recently also shown that the correlations between leptin and different measures of adiposity such as body mass index, subcutaneous skinfolds and waist and hip circumferences are similar. 33 Obese ob/ob mice have absent leptin which is responsible for their obesity. 34 In contrast, the db/db mouse has increased leptin concentrations suggesting resistance to the effects of leptin. 34 The db/db mouse appears to be a closer model for most human obesity. Although obese humans may be relatively resistant to leptin, reduction in body weight is associated with decreases in leptin concentrations. 11, 12 The action of leptin on the brain of rodents may be at the level of the hypothalamus. 35, 36 Recently, a leptin binding receptor OB-R, that is expressed in the mouse choroid plexus has been cloned. 37 Since there is considerable variability in leptin concentrations at a given level of obesity, other factors such as insulin resistance may also regulate leptin release or the response to leptin. Insulin has central effects on appetite regulation. 13 Insulin release is also effected by neural signals such as the cephalic-phase insulin response. 38 Our data suggest that in insulin resistant states there may be an increased resistance to the effects of leptin. One way to test this hypothesis might be the administration of agents that improve insulin sensitivity such as thiazolidinediones.
We also showed a relation between fasting glucose and leptin levels in these normoglycemic and relatively lean subjects. Previous reports have suggested that leptin concentrations are not increased in obese Mexican American subjects with NIDDM relative to obese non-diabetic Mexican Americans. 31 We also did not observe a signi®cant relation between leptin levels and fasting or 2 h glucose levels in non-diabetic Mexican American subjects. 17 However, Mexican Americans were considerably more obese than the current population. In the ob/ob mouse leptin administration decreased serum glucose levels but leptin administration to db/db mice did not. 39 These effects occurred before the reversal of the obesity syndrome. 39 Higher expression of ob mRNA levels have been reported after chronic exposure to elevated plasma insulin and/or glucose levels in lean mice. 40 Glucose may also be an important regulation of ob gene expression (and possibly of leptin) since Wister fatty (fa/fa) rats displayed both greater ob (mRNA) levels and increased glycemia compared to their lean litter mates during development (at 4, 12 and 30 weeks). 41 Thus our report of increased leptin levels with higher glucose levels in relatively lean normoglycemic subjects needs to be con®rmed by other reports.
Leptin concentrations reported in this study are low compared to other reports. 11, 12, 33 Part of the explanation is because the subjects were male and relatively lean. An additional factor explaining low leptin levels in this population compared to, for example, Mexican Americans where leptin levels were measured in the same laboratory 33 is that non-diabetic Mexican Americans are insulin resistant and hyperinsulinemic 42 whereas the Finnish subjects reported in this study 23 were picked to have normal glucose tolerance and free of clinical cardiac disease and thus were likely to be much more insulin sensitive.
Conclusions
We have shown that serum leptin levels were highly correlated with both insulin levels and insulin resistance in normoglycemic, predominantly non-obese men. These relationships were similar in more obese and less obese subjects. The associations in the present report were attenuated considerably after adjustment for obesity (and also body fat distribution) but remained statistically signi®cant. Our data thus suggested that hyperinsulinemia and insulin resistance per se could modify the response of leptin levels in the brain or alternatively affect resistance to the effects of leptin. This result is consistent with the rise in leptin observed in vivo and in vitro with long term insulin exposure. 20 
